Skip to main content
. 2019 Dec 30;111(2):312–322. doi: 10.1111/cas.14274

Figure 2.

Figure 2

The frequency of FLT3 mutations and co–occurring mutations in acute myeloid leukemia (AML) patients. The frequency of FLT3 mutations and co–occurring mutations in 199 AML patients who were registered in the Japan Adult Leukemia Study Group (JALSG) AML201 study. FLT3 mutation is the most frequently identified in AML patients (A), and frequently co–occurs with NPM1, DNMT3A, IDH1/2, TET2, GATA2 and KMT2A‐partial tandem duplication mutations (B). Figures are adopted from the reference 12